Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
NARecruitingINTERVENTIONAL
Enrollment
120
Participants
Timeline
Start Date
December 25, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DRUG
Neoadjuvant chemotherapy
Neoadjuvant chemotherapy
Trial Locations (1)
650118
RECRUITING
Yunnan Cancer Hospital, Kunming
All Listed Sponsors
lead
Yunnan Cancer Hospital
OTHER
NCT06735118 - Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver | Biotech Hunter | Biotech Hunter